A STUDY OF SHORT-TERM OUTCOMES AND ECONOMIC IMPACT FOR PATIENTS WITH WORSENING CONGESTIVE HEART FAILURE WHEN NATRECOR (NESIRITIDE) IS ADDED TO STANDARD-CARE THERAPY, COMPARED TO ADMINISTRATION OF PLACEBO WITH STANDARD-CARE THERAPY: